Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-30 Purchase |
2022-12-01 4:35 pm |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
1,502 | $6.657 | $10,000 | 6,142 (Direct) |
View |
| 2021-12-21 Purchase |
2021-12-22 6:21 pm |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
1,970 | $10.15 | $20,000 | 1,970 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-14 Equity Swap |
2024-02-14 4:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. President and CFO |
8,150 | $0 | 0 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 07:00 am |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 07:01 am |
N/A 2033-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A 2031-05-26 |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
0 | $0 | 355,999 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:49 pm |
N/A 2031-01-03 |
SELECTA BIOSCIENCES INC | SELB | Dahms Bradford D. Chief Financial Officer |
268,000 | $0 | 268,000 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-06 4:11 pm |
N/A 2030-06-30 |
SELECTA BIOSCIENCES INC | SELB | Dahms Bradford D. Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |